AzTrials
AzTrials

Leg ElevationNCT03617978

Passive Leg Raise During Cardiopulmonary Resuscitation

A study testing Hemodynamics parameters in people with Leg Elevation and Hemodynamic Instability, run by Lazarski University at 1 site in Poland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

during cardiopulmonary resuscitation, an important element of the procedure is to achieve optimal organ perfusion. For this purpose, high quality chest compressions is one of the basic elements of the procedure. however, similarly as in the case of hypovolemic shock, elevation of the lower limbs may be helpful. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Hemodynamics parameters
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 sitePoland
Study dates
1 Aug 2018to Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy participants
  • voluntary informed consent

Who cannot join

  • hip injury during the six months preceding the examination
  • back pain
  • kidney damage

Trial locations and contacts

1 site in 1 country.

Lukasz Szarpak, PhD contact

500186225

lukasz.szarpak@gmail.com

Jacek Smereka, PhD contact

601967070

smereka@pop.pl

Poland1 site, 1 recruiting
  • Faculty of Medicine, Lazarski University

    Warsaw, Masovian Voivodeship, 02-662

    Lukasz Szarpak, 500186225, lukasz.szarpak@gmail.com

    Recruiting

Other trials in Poland

About this study

Official title: Impact of Passive Leg Raise on Hemodynamic Effect: A Randomized Crossover Experimental Study

during cardiopulmonary resuscitation, an important element of the procedure is to achieve optimal organ perfusion. For this purpose, high quality chest compressions is one of the basic elements of the procedure. however, similarly as in the case of hypovolemic shock, elevation of the lower limbs may be helpful. The study is a randomized cross-over study and includes the effect of lower limb elevation on hemodynamic parameters in healthy participants.

Being tested
Hemodynamics parameters
Keywords
cardiopulmonary resuscitation, hemodynamic, medical simulation, leg elevation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hemodynamics parametersProcedure or surgery

    real-time evaluation of cardiac output parameters using the ICON device

Study groups in NCT03617978
Study groupRoleWhat they receive
None ElevationExperimentalParticipant placed on a flat surface. Study participant connected to the measuring hemodynamic parameters device
Receives: Procedure: Hemodynamics parameters
Elevation angle of 20 degreesExperimentalParticipant placed on a flat surface, lower limbs raised and supported at an angle of 20 degrees. Study participant connected to the measuring hemodynamic parameters device
Receives: Procedure: Hemodynamics parameters
Elevation angle of 30 degreesExperimentalParticipant placed on a flat surface, lower limbs raised and supported at an angle of 30 degrees. Study participant connected to the measuring hemodynamic parameters device
Receives: Procedure: Hemodynamics parameters
Elevation angle of 45 degreesExperimentalParticipant placed on a flat surface, lower limbs raised and supported at an angle of 45 degrees. Study participant connected to the measuring hemodynamic parameters device
Receives: Procedure: Hemodynamics parameters

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cardiac output - CO

    the volume of blood that the heart pumps into blood vessels in one minute. It is the product of the frequency of heart contractions (HR) and stroke volume (SV). The parameter is measured using ICON device

    Measured: during procedure

Secondary outcomes (2)
  1. Stroke Volume - SV

    the amount of blood pressed through one of the heart chambers into the appropriate arterial reservoir during a single heart contraction. The parameter is measured using ICON device

    Measured: during procedure

  2. thoracic fluid content - TFC

    It is an indicator of total fluid volume, both intracellular and extracellular. The parameter is measured using ICON device

    Measured: during procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2018
  2. Study start1 Aug 2018
  3. Primary completionSep 2018 (estimated)
  4. Study completionSep 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03617978
Sponsor's protocol ID
PLR_2018_UL
Status last verified
Aug 2018
First submitted
1 Aug 2018
Last updated
7 Aug 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data will be available at the main author

Questions about this trial

What is this clinical trial studying?

A study testing Hemodynamics parameters in people with Leg Elevation and Hemodynamic Instability, run by Lazarski University at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lukasz Szarpak, PhD (500186225, lukasz.szarpak@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cardiac output - CO (time frame: during procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in